Donate to AGSD

Thank you for your support!

Become a Member

Access to scholarships, events, and more!

Ultragenyx Update: DTX401 BLA Accepted

The U.S. FDA has granted Priority Review for the Biologics License Application (BLA) for our investigational gene therapy for Glycogen Storage Disease Type Ia (GSDIa).